Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)
Clinical trial NCT00160563 · TERMINATED
Trial details
- NCT number
- NCT00160563
- Sponsor
- UCB Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2006-03-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.